Godavari Drugs Limited (BOM:530317)
85.68
-4.35 (-4.83%)
At close: Mar 27, 2026
Godavari Drugs Market Cap
Godavari Drugs has a market cap or net worth of 645.21 million as of March 27, 2026. Its market cap has decreased by -12.80% in one year.
Market Cap
645.21M
Enterprise Value
1.36B
Revenue
986.94M
Ranking
n/a
PE Ratio
17.45
Stock Price
85.68
Market Cap Chart
Since April 30, 2001, Godavari Drugs's market cap has increased from 15.34M to 645.21M, an increase of 4,105.25%. That is a compound annual growth rate of 16.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 645.21M | 11.52% |
| Dec 31, 2025 | 578.57M | -29.74% |
| Dec 31, 2024 | 823.46M | 21.42% |
| Dec 29, 2023 | 678.20M | -5.10% |
| Dec 30, 2022 | 714.64M | 51.48% |
| Dec 31, 2021 | 471.79M | 79.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mercury Laboratories | 973.20M |
| Concord Drugs | 943.33M |
| Makers Laboratories | 896.56M |
| Source Natural Foods and Herbal Supplements | 752.48M |
| Accretion Pharmaceuticals | 736.99M |
| Amwill Health Care | 640.92M |
| Asston Pharmaceuticals | 595.91M |
| Onyx Biotec | 562.10M |